Tamer I. Khayal, Chief Commercial Officer at TransMedics Group, Inc. (TMDX), sold 119,264 shares at $121.21 ($12.9M) on 2024-05-01, disclosed to the SEC on 2024-05-14.
Scheduled sale ($12.9M) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $105.71 | 11,051 | $1.2M | 9.0% |
| 2 | $105.71 | 11,051 | $1.2M | 9.0% |
| 3 | $106.25 | 14,854 | $1.6M | 12.2% |
| 4 | $106.25 | 14,854 | $1.6M | 12.2% |
| 5 | $107.20 | 11,789 | $1.3M | 9.8% |
| 6 | $107.20 | 11,789 |
| $1.3M |
| 9.8% |
| 7 | $108.35 | 1,792 | $194K | 1.5% |
| 8 | $108.35 | 1,792 | $194K | 1.5% |
| 9 | $109.68 | 13,078 | $1.4M | 11.1% |
| 10 | $109.68 | 13,078 | $1.4M | 11.1% |
| 11 | $110.00 | 5,313 | $584K | 4.5% |
| 12 | $113.16 | 100 | $11K | 0.1% |
| 13 | $116.80 | 326 | $38K | 0.3% |
| 14 | $117.97 | 759 | $90K | 0.7% |
| 15 | $117.97 | 759 | $90K | 0.7% |
| 16 | $119.00 | 1,417 | $169K | 1.3% |
| 17 | $119.96 | 1,815 | $218K | 1.7% |
| 18 | $119.96 | 1,815 | $218K | 1.7% |
| 19 | $121.21 | 422 | $51K | 0.4% |
| 20 | $121.21 | 422 | $51K | 0.4% |
| 21 | $121.84 | 444 | $54K | 0.4% |
| 22 | $121.84 | 444 | $54K | 0.4% |
| 23 | $123.66 | 100 | $12K | 0.1% |
| Total | $108.31 avg | 119,264 | $12.9M | 100% |
| Filing → |
| TMDX | SELL | 2024-12-04 | $187K | — | Filing → |
| TMDX | SELL | 2024-11-13 | $263K | — | Filing → |
| TMDX | SELL | 2024-11-05 | $179K | — | Filing → |